INTRODUCTION: Repeated short-term hypoxia (interval hypoxia) has been suggested to increase exercise tolerance by enhancing stress resistance and/or improving oxygen delivery. As low exercise tolerance contributes to mortality in patients with coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD), interval hypoxia might be a valuable preventive and therapeutic tool for these patients. Yet, mechanisms responsible for the improvement of exercise tolerance are still largely unknown. Therefore, this review intends to present an overview for better understanding of such mechanisms and to stimulate further research work on this important topic. DATA SOURCE: Articles were selected from a search of the PubMed database up to 2009 using the search terms hypoxia, intermittent, interval in various combinations with exercise, capacity, tolerance, CAD, COPD, and various haematological and cardio-respiratory parameters. RESULTS: Generally, the effects of 2-4 weeks of interval hypoxia on exercise tolerance are contrasting. Whereas aerobic exercise performance improved or remained unchanged, anaerobic performance tended even to worsen. Benefits on exercise tolerance seem to be greater in patients with CAD or COPD when compared to healthy subjects. DISCUSSION: The mechanisms responsible for these benefits are the increases in total haemoglobin mass, lung diffusion capacity, more efficient ventilation, and a decrease in the responsiveness of the adrenergic system to stimulation and/or an increase in parasympathetic activity. If confirmed in further studies, interval hypoxia might become an attractive strategy to complement the known beneficial effects of exercise training, especially in patients with CAD or COPD.
INTRODUCTION: Repeated short-term hypoxia (interval hypoxia) has been suggested to increase exercise tolerance by enhancing stress resistance and/or improving oxygen delivery. As low exercise tolerance contributes to mortality in patients with coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD), interval hypoxia might be a valuable preventive and therapeutic tool for these patients. Yet, mechanisms responsible for the improvement of exercise tolerance are still largely unknown. Therefore, this review intends to present an overview for better understanding of such mechanisms and to stimulate further research work on this important topic. DATA SOURCE: Articles were selected from a search of the PubMed database up to 2009 using the search terms hypoxia, intermittent, interval in various combinations with exercise, capacity, tolerance, CAD, COPD, and various haematological and cardio-respiratory parameters. RESULTS: Generally, the effects of 2-4 weeks of interval hypoxia on exercise tolerance are contrasting. Whereas aerobic exercise performance improved or remained unchanged, anaerobic performance tended even to worsen. Benefits on exercise tolerance seem to be greater in patients with CAD or COPD when compared to healthy subjects. DISCUSSION: The mechanisms responsible for these benefits are the increases in total haemoglobin mass, lung diffusion capacity, more efficient ventilation, and a decrease in the responsiveness of the adrenergic system to stimulation and/or an increase in parasympathetic activity. If confirmed in further studies, interval hypoxia might become an attractive strategy to complement the known beneficial effects of exercise training, especially in patients with CAD or COPD.
Authors: Valeriy B Shatilo; Oleg V Korkushko; Vadim A Ischuk; H Fred Downey; Tatiana V Serebrovskaya Journal: High Alt Med Biol Date: 2008 Impact factor: 1.981
Authors: Maria del Pilar Valle; Félix García-Godos; Orison O Woolcott; José M Marticorena; Víctor Rodríguez; Isabel Gutiérrez; Luis Fernández-Dávila; Abel Contreras; Luis Valdivia; Juan Robles; Emilio A Marticorena Journal: J Nucl Cardiol Date: 2006 Jan-Feb Impact factor: 5.952
Authors: Zhihao Zhang; Ting Wang; Jin Kuang; Fabian Herold; Sebastian Ludyga; Jingming Li; Daniel L Hall; Alyx Taylor; Sean Healy; Albert S Yeung; Arthur F Kramer; Liye Zou Journal: Int J Clin Health Psychol Date: 2022-06-03
Authors: Oleg S Glazachev; Svetlana Yu Kryzhanovskaya; Maxim A Zapara; Elena N Dudnik; Vlada G Samartseva; Davide Susta Journal: Curr Cardiol Rev Date: 2021
Authors: Denis S Tuter; Philippe Y Kopylov; Abram L Syrkin; Oleg S Glazachev; Roman N Komarov; Andrei I Katkov; Ljudmila P Severova; Ekaterina V Ivanova; Young Zhang; Hugo Saner Journal: Open Heart Date: 2018-11-10
Authors: Aleksandra Żebrowska; Dariusz Jastrzębski; Ewa Sadowska-Krępa; Marcin Sikora; Camillo Di Giulio Journal: Biomed Res Int Date: 2019-09-22 Impact factor: 3.411